Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Pivot Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Target Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Query: UNIPROT:P00750 (
PLA
)
16,800
document(s) hit in 31,850,051 MEDLINE articles (0.00 seconds)
Group IIa phospholipase A(2) (GIIa
PLA
(2)) is released by some cells in response to interleukin-1beta. The purpose of this study was to determine whether interleukin-1beta would stimulate the synthesis and release of GIIa
PLA
(2) from cardiomyocytes, and to define the role of p38 MAPK and cytosolic
PLA
(2) in the regulation of this process. Whereas GIIa
PLA
(2) mRNA was not identified in untreated cells, exposure to interleukin-1beta resulted in the sustained expression of GIIa
PLA
(2) mRNA. Interleukin-1beta also stimulated a progressive increase in cellular and extracellular GIIa
PLA
(2) protein levels and increased extracellular
PLA
(2) activity 70-fold. In addition, interleukin-1beta stimulated the p38 MAPK-dependent activation of the downstream
MAPK-activated protein kinase
, MAPKAP-K2. Treatment with the p38 MAPK inhibitor, SB202190, decreased interleukin-1beta stimulated MAPKAP-K2 activity, GIIa
PLA
(2) mRNA expression, GIIa
PLA
(2) protein synthesis, and the release of extracellular
PLA
(2) activity. Infection with an adenovirus encoding a constitutively active form of MKK6, MKK6(Glu), which selectively phosphorylates p38 MAPK, induced cellular GIIa
PLA
(2) protein synthesis and the release of GIIa
PLA
(2) and increased extracellular
PLA
(2) activity 3-fold. In contrast, infection with an adenovirus encoding a phosphorylation-resistant MKK6, MKK6(A), did not result in GIIa
PLA
(2) protein synthesis or release by unstimulated cardiomyocytes. In addition, infection with an adenovirus encoding MKK6(A) abrogated GIIa
PLA
(2) protein synthesis and release by interleukin-1beta-stimulated cells. These results provide direct evidence that p38 MAPK activation was necessary for interleukin-1beta-induced synthesis and release of GIIa
PLA
(2) by cardiomyocytes.
...
PMID:p38 MAPK regulates group IIa phospholipase A2 expression in interleukin-1beta -stimulated rat neonatal cardiomyocytes. 1157 Dec 75